Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts

BACKGROUND AND OBJECTIVES: 2018 ESC/ESH Hypertension guideline recommends 2-drug combination as initial anti-hypertensive therapy. However, real-world evidence for effectiveness of recommended regimens remains limited. We aimed to compare the effectiveness of first-line anti-hypertensive treatment c...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Seng Chan, Jung, Sungjae, Swerdel, Joel N., Ryan, Patrick B., Schuemie, Martijn J., Suchard, Marc A., Lee, Seongwon, Cho, Jaehyeong, Hripcsak, George, Park, Rae Woong, Park, Sungha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923236/
https://www.ncbi.nlm.nih.gov/pubmed/31642211
http://dx.doi.org/10.4070/kcj.2019.0173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923236/
https://www.ncbi.nlm.nih.gov/pubmed/31642211
http://dx.doi.org/10.4070/kcj.2019.0173

Ejemplares similares